Company Overview
About Kriya Therapeutics
Kriya Therapeutics is a gene therapy company founded in 2019 by Saket Bhargava and Chintan Shah, headquartered in Research Triangle Park, North Carolina. The company is building a platform for adeno-associated virus (AAV) gene therapy specifically targeting chronic metabolic and cardiovascular diseases — conditions where a single gene therapy treatment could potentially replace a lifetime of injectable or oral medications. Kriya's therapeutic thesis is that gene therapy, historically applied to rare genetic diseases, can be extended to larger-prevalence conditions like type 2 diabetes, obesity, and lipid disorders — unlocking much larger commercial markets than orphan drug gene therapy programs.
Business Model & Competitive Advantage
Kriya's core differentiation is its proprietary vector engineering platform, which optimizes AAV capsid design, promoter selection, and payload construct to improve tissue specificity, reduce immunogenicity (the immune system's reaction to the viral vector), and enable redosing — long-standing barriers to broader gene therapy adoption. The platform integrates de novo construct design, targeted sequence modification, and data analysis tools, enabling Kriya to systematically engineer improved vectors rather than relying on naturally occurring AAV serotypes. This computational and synthetic biology capability is the central R&D asset the company is building toward IND-enabling studies and eventual clinical trials.
Competitive Landscape 2025–2026
Kriya Therapeutics raised a $150M Series C in 2022 led by Premji Invest (the family office of Wipro's Azim Premji), with participation from Mubadala Investment Company, Decheng Capital, Foresite Capital, and others — bringing total funding to $270M. The company is building manufacturing capabilities and pursuing multiple pipeline programs. Kriya competes in the gene therapy developer space with BioMarin Pharmaceutical, Spark Therapeutics (Roche), Ultragenyx Pharmaceutical, and a number of well-capitalized private gene therapy startups targeting overlapping disease areas and AAV platform technology.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Karius
Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Compare Kriya Therapeutics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Kriya Therapeutics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Kriya Therapeutics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Kriya Therapeutics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →